Skip to content
A
  • HomeHome
  • SearchSearch
  • AskAsk
  • FollowingFollowing
  • SavedSaved

Mark H. Einstein

Organisation

Trials

  • NCT00231829

    Phase 2Terminated200323 people4 Oct 2005clinicaltrials.gov

© 2026 AgingResearch.News

PrivacyTermsContact

    News

    See all →

    ER-100 glaucoma trial findings support testing higher doses

    TrialsLongevity.Technology and 1 more

    Nicotinamide riboside fails to show clinical benefit in yearlong Parkinson's trial

    TrialsMedical Xpress and 1 more

    Study links faster aging in larger dogs to epigenomic changes

    ResearchNature and 1 more

    Trials

    See all →

    Registered6 Oct 2026

    AKG and Brain Health in Aging

    Phase 2 · University of Oklahoma

    Registered25 Sept 2026

    The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease

    University Hospital, Akershus

    Registered2 Oct 2026

    Safety and Preliminary Efficacy of Adipose-Derived Stem Cell Secretome in Frailty (VinVital)

    Phase 1 · Vinmec Research Institute of Stem Cell and Gene Technology

    Trending

    Evidence →
    1. Intervention · 65 papersExercise
    2. Gene · 28 papersAPOE
    3. Disease · 124 papersCardiovascular disease
    4. Process · 131 papersInflammation
    5. Biomarker · 58 papersBody mass index
    6. Intervention · 40 papersSmoking

    Topics

    See all →
    • Mechanisms311
    • Interventions485
    • Biomarkers484
    • Populations612
    • AI & data184
    • Industry & policy23
    • Privacy
    • Terms
    • Contact
    • © 2026 AgingResearch.News